Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 63.40
-0.80 (-1.25%)
Aug 14, 2026, 5:20 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.07 billion as of August 14, 2026. Its market cap has decreased by -55.80% in one year.
Market Cap
1.07B
Enterprise Value
1.04B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
63.40
ChartMarket Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has decreased from 1.35B to 1.07B, a decrease of -20.78%. That is a compound annual growth rate of -4.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 1.07B | -43.70% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CellaVision AB | 3.63B |
| C-Rad AB | 1.21B |
| BICO Group AB | 1.17B |
| Sedana Medical AB | 1.12B |
| Paxman AB | 1.06B |
| Senzime AB | 628.07M |
| Bactiguard Holding AB | 544.93M |
| OssDsign AB | 486.20M |